SCHEMBL10114624

SCHEMBL10114624

COOSCCc1csc(NC(=O)c2ccc(OC(C)=O)c(Cl)c2)n1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.42
CPT1A P50416 8/20 0.42
CPT1B Q92523 8/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SCD O00767 1/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932516 0.83 ALDH1A1 (0.45) ALDH1A1RAB9ACPT1ACPT1BLMNA
SCHEMBL10114592 0.83 SCD (0.48) RAB9ACPT1ACPT1BLMNASCD
SCHEMBL10114477 0.82 GRM5 (0.46) ALDH1A1RAB9ACPT1ACPT1BLMNA
SCHEMBL4757358 0.71 MAPT (0.50) ALDH1A1RAB9ALMNASCDMAPT
SCHEMBL27713512 0.69 MAPT (0.53) LMNASCDMAPTADORA3CYP1A2
SCHEMBL10114444 0.68 MAPT (0.40) ALDH1A1RAB9ALMNANPSR1HSD17B10
SCHEMBL4938271 0.66 SCD (0.48) RAB9ACPT1ACPT1BLMNASCD
SCHEMBL16257639 0.66 PDE5A (0.40) ALDH1A1LMNANPSR1HSD17B10MAPT
SCHEMBL10131601 0.65 GRM5 (0.47) LMNAMAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL10114623 0.64 ALDH1A1 (0.41) ALDH1A1RAB9ALMNANPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC ALDH1A1 1605/4885RAB9A 1694/4885CPT1A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.